Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

The Cannigma to Be Featured on Ted Danson's CNBC Show

Science-based cannabis educator The Cannigma helps patients, doctors, and even lawmakers understand the science of cannabis so they can make better and smarter choices about the plant.

The Cannigma's logo

News provided by

The Cannigma

21 Apr, 2021, 19:30 IDT

Share this article

Share toX

Share this article

Share toX

HERZLIYA, Israel, April 21, 2021 /PRNewswire/ -- CNBC's "Advancements With Ted Danson" is scheduled to run a special feature on science-based cannabis publisher The Cannigma in its upcoming episode this Saturday, April 24.

Featuring Cannigma CEO Elana Goldberg, cannabis researcher and pediatrician Dr. Orit Stolar, and Perry Davidson, CEO of medical vaporizer company Syke, the segment explains why progress in the field of cannabis is dependent upon educating the broader public about the plant.

"Education is going to be crucial when it comes to the cannabis industry expanding," explains Goldberg in the episode. "If lawmakers properly understand what we now know from cannabis research about the plant, they are going to be able to make the right laws which are going to help cannabis businesses really thrive."

Once that type of regulatory transformation takes place, Goldberg continues, "researchers are going to be able to look into the myriad uses for the plant, healthcare providers will have all of the information they need to treat their patients well."

The tools being developed by The Cannigma are an important pillar of that massive undertaking of educating the world about cannabis and allowing anyone to make decisions for themselves about the plant — based on reliable scientific research.

After airing on CNBC, the episode will be available for streaming on Amazon Prime.

The Cannigma is a cannabis content platform that creates and distributes cannabis information, products and services while maintaining an unbiased scientific approach.

For more information, visit https://www.cannigma.com

Press Contact:
[email protected]

Related Images

the-cannigma-logo.jpg
The Cannigma logo
The Cannigma's logo

SOURCE The Cannigma

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.